Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database

被引:6
作者
Cheung, Jason [1 ]
Puhr, Rainer [3 ]
Petoumenos, Kathy [3 ]
Cooper, David A. [3 ,4 ]
Woolley, Ian [7 ]
Gunathilake, Manoji [3 ,8 ]
Raymond, Nigel [9 ]
Varma, Rick [3 ,5 ]
O'Connor, Catherine C. [2 ,3 ,6 ]
Gracey, David M. [1 ]
机构
[1] Royal Prince Alfred Hosp, Renal Unit, Missenden Rd, Sydney, NSW 2050, Australia
[2] Sydney Local Hlth Dist, Sexual Hlth Serv, Sydney, NSW, Australia
[3] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia
[4] St Vincents Hlth Network Sydney, St Vincents Hosp, HIV Immunol & Infect Dis Unit, Sydney, NSW, Australia
[5] South Eastern Sydney Local Hlth Dist, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia
[6] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia
[7] Monash Univ, Monash Infect Dis, Melbourne, Vic, Australia
[8] Ctr Dis Control, Sexual Hlth & Blood Bourne Virus Unit, Dept Hlth, Darwin, NT, Australia
[9] Capital & Coast DHB, Infect Serv, Wellington, New Zealand
基金
美国国家卫生研究院;
关键词
AIDS-associated nephropathy; chronic; HIV; HIV infections; kidney diseases; renal insufficiency; STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; ANTIRETROVIRAL THERAPY; INCOME COUNTRIES; RISK-FACTORS; LARGE COHORT; ASSOCIATION; EPIDEMIOLOGY; INDIVIDUALS; PREVENTION;
D O I
10.1111/nep.13100
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
AimThe aim of the present study was to examine data from the Australian HIV Observational Database (AHOD), and firstly, to describe the incidence of chronic kidney disease (CKD) and the rate of loss of renal function in HIV-infected individuals living in Australia, and then to examine the risk factors contributing to CKD in this population. MethodsAHOD patients over 18 years of age were eligible if they had at least two serum creatinine measurements from 1 April 2008 until 31 March 2016 and an initial estimated glomerular filtration rate (eGFR) greater than 60 mL/min per 1.73 m(3). Cox proportional hazards models were used to assess risk factors for CKD, which included key patient demographic data and antiretroviral therapy (ART) exposure. ResultsOf 1924 patients included in the analysis between April 2008 and March 2016, 81 (4.2%) developed CKD (confirmed eGFR of less than 60 mL/min per 1.73 m(3) through two consecutive eGFR measurements at least 3 months apart). Of the examined risk factors, baseline age, baseline eGFR, and the route of HIV acquisition were statistically significant predictors of development of CKD. ART exposure, viral hepatitis co-infection, high viral load and low CD4 lymphocyte count were not found to be significant risk factors for CKD. ConclusionThis is the first study to investigate the risk factors for development of CKD among Australian HIV-infected patients using cohort data. It highlights the need for awareness of renal risk factors, particularly among older patients or in those with pre-existing renal dysfunction. Further research is required to explore the discrepancy between patients who have acquired HIV through different means of exposure. Summary at a Glance This paper describes the incidence of CKD and rate of progression of CKD in a large Australian population with HIV using the Australian HIV Observational Database.
引用
收藏
页码:778 / 786
页数:9
相关论文
共 28 条
  • [1] [Anonymous], OVERVIEW CHRONIC KID
  • [2] Clinical epidemiology of HIV-associated end-stage renal failure in the UK
    Bansi, Loveleen
    Hughes, Amelia
    Bhagani, Sanjay
    Mackie, Nicola E.
    Leen, Clifford
    Levy, Jeremy
    Edwards, Simon
    Connolly, John
    Holt, Steve G.
    Hendry, Bruce M.
    Sabin, Caroline
    Post, Frank A.
    [J]. AIDS, 2009, 23 (18) : 2517 - 2521
  • [3] Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study
    Brown, TT
    Cole, SR
    Li, XH
    Kingsley, LA
    Palella, FJ
    Riddler, SA
    Visscher, BR
    Margolick, JB
    Dobs, AS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) : 1179 - 1184
  • [4] Racial differences in end-stage renal disease rates in HIV infection versus diabetes
    Choi, Andy I.
    Rodriguez, Rudolph A.
    Bacchetti, Peter
    Bertenthal, Daniel
    Volberding, Paul A.
    O'Hare, Ann M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (11): : 2968 - 2974
  • [5] Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: Results from National HIV Behavioral Surveillance 2005-2012
    Coffina, Phillip O.
    Jin, Harry
    Huriaux, Ernalie
    Mirzazadeh, Ali
    Raymond, Henry F.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2015, 146 : 45 - 51
  • [6] Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
  • [7] Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care
    Kalayjian, Robert C.
    Lau, Bryan
    Mechekano, Rhoderick N.
    Crane, Heidi M.
    Rodriguez, Benigno
    Salata, Robert A.
    Krishnasami, Zipporah
    Willig, James H.
    Martin, Jeffrey N.
    Moore, Richard D.
    Eron, Joseph J.
    Kitahata, Mari M.
    [J]. AIDS, 2012, 26 (15) : 1907 - 1915
  • [8] KAUL S, 2003, 43 INT C ANT AG CHEM
  • [9] A New Equation to Estimate Glomerular Filtration Rate
    Levey, Andrew S.
    Stevens, Lesley A.
    Schmid, Christopher H.
    Zhang, Yaping
    Castro, Alejandro F., III
    Feldman, Harold I.
    Kusek, John W.
    Eggers, Paul
    Van Lente, Frederick
    Greene, Tom
    Coresh, Josef
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 604 - 612
  • [10] Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
    Lucas, Gregory M.
    Ross, Michael J.
    Stock, Peter G.
    Shlipak, Michael G.
    Wyatt, Christina M.
    Gupta, Samir K.
    Atta, Mohamed G.
    Wools-Kaloustian, Kara K.
    Pham, Paul A.
    Bruggeman, Leslie A.
    Lennox, Jeffrey L.
    Ray, Patricio E.
    Kalayjian, Robert C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (09) : E96 - E138